NKAPL and non-small cell lung carcinoma: According to the importance rank of methylation sites obtained via artificial intelligence machine learning-based analysis of the correlation between lung cancer methylation and clinical characteristics (data source: Genome Atlas Program, TCGA), NF-kappa-B-activating protein-like (NKAPL) has been identified as a potential marker in NSCLC because of its high specificity in distinguishing positive and negative samples.